(Sharecast News) - Schrödinger surged on Tuesday after it announced a $2.5bn research collaboration and license agreement with Novartis to advance multiple development candidates into the Swiss pharma firm's portfolio for further development.
Under the terms of the agreement, Novartis will pay Schrödinger $150m upfront and Schrödinger will also be eligible...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE